JWK-002

N/A

Report date: 2025/06/27 20:00:57

Base Information

Drug NameJWK-002
Drug Alias NameJWK-002JWK002
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionRetinoschisin gene transference
TargetsRetinoschisin
Therapy Area/IndicationsRetinoschisis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesChengdu Genevector Biotechnology Co LtdWuhan Jinweike Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesWuhan Jinweike Biotechnology Co LtdChengdu Genevector Biotechnology Co LtdWest China Hospital Of Sichuan University
Inactive CompaniesN/A
Active IndicationsRetinoschisis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A